Status:
UNKNOWN
Can Fasting Decrease the Side Effects of Chemotherapy?
Lead Sponsor:
Sutter Health
Conditions:
Chemotherapy Effect
Chemotherapeutic Toxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective randomized crossover trial. Patients will be randomized to the FMD or regular diet during three rounds of chemotherapy. After the third round, patients will cross over to the opp...
Detailed Description
Randomization and blinding: Subjects will be allocated to sequence 1 (normal diet first, FMD second) or sequence 2 (FMD first, normal diet second) using a computer generated randomization scheme. The...
Eligibility Criteria
Inclusion
- 18 years of age and older
- English speaking
- Patients undergoing chemotherapy with Taxol/carboplatin planned for at least 6 cycles
- Willing to comply with diet and tests
- No significant medical problem that would make fasting dangerous (insulin dependent diabetes, history of hypoglycemia)
Exclusion
- Insulin dependent diabetes
- Pregnancy
- History of hypoglycemia, or any other medical condition that the treating physician considers not suitable for fasting
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04027478
Start Date
September 1 2019
End Date
February 1 2021
Last Update
July 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sutter Cancer Center
Sacramento, California, United States, 95816